Indraprastha Medical Corporation: Mr. Shivakumar Pattabhiraman (DIN 08570283) has completed his tenure as Managing Director of the Company,…

What happened

Indraprastha Medical Corporation (INDRAMEDCO) filed a disclosure with the exchanges on 5 November 2026 at 10:31 AM titled "Mr. Shivakumar Pattabhiraman (DIN 08570283) has completed his tenure as Managing Director of the Company, effective from the close of the day on 4th November".

Company snapshot

Indraprastha Medical Corporation is a small-cap company, with a market value of about ₹2,919 crore.

The stock last traded at ₹318.4, against a 52-week range of ₹293.7–₹640.9 (50.3% below the high).

Before this filing the shares had moved −6.0% over the month and −14.1% over three months. Average daily turnover over the last 20 sessions was about ₹5.26 crore.

Promoters held 51.00% at the end of Q2 FY27. Foreign institutions owned 2.39% and domestic institutions 1.77%.

What history shows

BCEIE has no earlier management change filing from this company on record since May 2026.

Market-wide, 4,282 management change filings with an impact score of 50 or more saw an average next-day move of −0.1%, with 44% rising.

Past reactions describe what happened before; they are not a forecast.

What to watch

• The appointment of a successor and any change in strategy or guidance.

In the news

Recent coverage elsewhere (links open the original publisher):

• Indraprastha Medical Corporation Sept-Quarter PAT 535.8 Million Rupees — TradingView, 29 Oct 2026
• Indraprastha Medical Corporation Limited (INDRAMEDCO.BO) Seasonal Returns Chart - Yahoo Finance — Yahoo! Finance Canada, 3 Nov 2026
• Indraprastha Medical Corporation Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2026 — www.marketscreener.com, 30 Oct 2026
• Indraprastha Medical Q2 EBITDA margin slips to 18.68% as costs rise — scanx.trade, 31 Oct 2026
• Indraprastha Medical (NSEI:INDRAMEDCO) - Stock Analysis — Simply Wall St, 2 Nov 2026

Source

• Exchange filing (PDF)